Skip to main content
Premium Trial:

Request an Annual Quote

Kevin King, Matthew Robin, Carl Severinghaus, Thomas Bachmann

Premium
Affymetrix has named Kevin King as executive vice president and president of its life sciences business, the company said in late December.
 
King previously worked at Thomson Healthcare, where he oversaw growth and expansion, and he served as vice president and general manager at General Electric Healthcare and he spent 14 years with Hewlett-Packard.
 

 
Swiss compounds research company Tecan last month said its board of directors has appointed Matthew Robin and Carl Severinghaus to its group executive committee.
 
Robin will be responsible for the company’s liquid-handling and robotics business, which is currently being managed by CEO Thomas Bachmann. Robin previously was CEO of medical technology company Ypsomed.

 

Severinghaus worked previously with Beckman Coulter and the American Monitor Corporation, and has 15 years experience working at Tecan.
 
In his new position he will manage the company’s direct sales organization.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.